It may be harmful to the teeth
Dosing Protocols and Titration Start at a low dose to mitigate side effects (nausea, gastrointestinal upset) and increase gradually per approved or clinically supported protocol
External resources Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment (PubMed Central) Spotlight on the Mechanism of Action of Semaglutide (PubMed Central) How Does Ozempic Work
Whos qualified for GLP-1 Bridge program To be eligible, a patient must meet one of these three conditions: Have a body mass index (BMI) of 35 or more Have a BMI between 30-34.99 and at least one of these conditions: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled hypertension (high blood pressure) Chronic kidney disease at stage 3a or higher Prediabetes A previous heart attack or stroke Peripheral artery disease with symptoms Or, have a BMI between 27-29.99 and at least one of these conditions: Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms Patients are not eligible if they fall into these categories: If they already are covered for a GLP-1 through Part D Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, in which case, they may already be covered by their Part D plans This article first appeared on Bridge Michigan and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License
Alsubaie QD, Al-Amri AA, Siddiqui MH, Alamri S (2024) Strigolactone and nitric oxide collaborate synergistically to boost tomato seedling resilience to arsenic toxicity via modulating physiology and antioxidant system
